Clinical trials
Sjogren's Syndrome trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 3 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 11 |
| Unknown status | 8 |
| Active, not recruiting | 7 |
| Not yet recruiting | 3 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Amgen | 5 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| University Hospital, Brest | 5 |
| University Hospital, Montpellier | 4 |
| Bristol-Myers Squibb | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| GlaxoSmithKline | 2 |
| Janssen Research & Development, LLC | 2 |
| University Hospital, Bordeaux | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sjogren's Syndrome | 55 |
| Arthritis, Rheumatoid | 13 |
| Lupus Erythematosus, Systemic | 11 |
| Autoimmune Diseases | 8 |
| Scleroderma, Diffuse | 6 |
| Scleroderma, Systemic | 6 |
| Myositis | 4 |
| Xerostomia | 4 |
| Arthritis, Psoriatic | 3 |
| Connective Tissue Diseases | 3 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.